May 15, 2024
“Shares of Novavax closed nearly 50% higher on Monday as Wall Street cheered the company’s new multibillion-dollar deal with French drugmaker Sanofi that sparked a dramatic turnaround for the struggling vaccine maker. Novavax’s stock almost doubled on Friday after it announced the licensing agreement with Sanofi. Novavax on… Continue Reading…
May 14, 2024
“Novavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company’s Covid vaccine starting next year and develop combination shots targeting the coronavirus and the flu, among other efforts. Shares of Novavax closed nearly 100% higher on Friday from… Continue Reading…
August 13, 2020
“What happened Coronavirus-related stocks declined sharply on Wednesday, extending their losses following Russia’s announcement on Tuesday that it had developed the world’s first COVID-19 vaccine. As of 11:55 a.m. EDT, shares of Novavax (NASDAQ:NVAX), Heat Biologics (NASDAQ:HTBX), Sorrento Therapeutics (NASDAQ:SRNE), Vaxart (NASDAQ:VXRT), and iBio (NYSEMKT:IBIO) were down 20%, 17%, 15%, 14%,… Continue Reading…
January 22, 2020
“Yesterday, next-generation vaccine maker Novavax (NASDAQ:NVAX) saw its shares jump by an astounding 71% on nearly 24 times the average daily volume. Investors bid up this small-cap biotech stock in response to the spread of a deadly respiratory virus (a type of coronavirus) from China… Continue Reading…
Recent Comments